Forum für Wissenschaft, Industrie und Wirtschaft

Hauptsponsoren:     3M 
Datenbankrecherche:

 

Metformin offers cardio benefits over sulfonylureas in diabetes

08.11.2012
A Vanderbilt study examining the impact of the two most commonly prescribed oral diabetes medications on the risk for heart attack, stroke and death has found the drug metformin has benefits over sulfonylurea drugs.

It was important to examine the cardiovascular impact of the more commonly used diabetes drugs after recent controversy surrounded another diabetes medication, rosiglitazone, because it was associated with an increased cardiac risk, said lead author, Christianne L. Roumie, M.D., MPH, assistant professor of Internal Medicine and Pediatrics. Smaller studies pointed to a potential advantage of taking the drug metformin but this study confirms this in a large population.

"We demonstrated that for every 1,000 patients who are using metformin for a year there are two fewer heart attacks, strokes or deaths compared with patients who use sulfonylureas. I think this reinforces the recommendation that metformin should be used as the first medication to treat diabetes," Roumie said.

The researchers looked at the charts of more than 250,000 veterans receiving care in Veterans Health Administration hospitals throughout the United States. The patients were started on oral therapy for their diabetes with either metformin or a sulfonylurea and followed for about a year. Results are in the Nov. 6 issue of Annals of Internal Medicine.

"Both drugs do a good job helping control diabetes and preventing nerve damage and eye disease associated with high sugar levels. We did this study because there was an important knowledge gap about whether metformin was superior to sulfonylureas for prevention of heart disease, stroke and death," said senior author Marie R. Griffin M.D., MPH, professor of Preventive Medicine.

The limitations of the study include that neither patient group was compared with diabetic patients who take no oral medications, and that the veteran patients were mostly men.

Metformin is already the recommended first-line therapy for those needing oral medication to control type 2 diabetes. The most common side effect is stomach upset, which can often be overcome by titrating the dosage up slowly. It has not been recommended that patients with kidney impairment take metformin, so sulfonylureas might be a better choice for those patients.

Roumie said this study suggests it might be prudent to take a second look at those patients who have been taking sulfonylureas to see if a switch to metformin might be recommended.

Craig Boerner | EurekAlert!
Further information:
http://www.vanderbilt.edu

Further reports about: Internal Medicine Medicine Metformin diabetes drug diabetes medication

More articles from Health and Medicine:

nachricht Another reason to exercise: Burning bone fat -- a key to better bone health
19.05.2017 | University of North Carolina Health Care

nachricht Disrupted fat breakdown in the brain makes mice dumb
19.05.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Tumult im trägen Elektronen-Dasein

Ein internationales Team von Physikern hat erstmals das Streuverhalten von Elektronen in einem nichtleitenden Material direkt beobachtet. Ihre Erkenntnisse könnten der Strahlungsmedizin zu Gute kommen.

Elektronen in nichtleitenden Materialien könnte man Trägheit nachsagen. In der Regel bleiben sie an ihren Plätzen, tief im Inneren eines solchen Atomverbunds....

Im Focus: Turmoil in sluggish electrons’ existence

An international team of physicists has monitored the scattering behaviour of electrons in a non-conducting material in real-time. Their insights could be beneficial for radiotherapy.

We can refer to electrons in non-conducting materials as ‘sluggish’. Typically, they remain fixed in a location, deep inside an atomic composite. It is hence...

Im Focus: Hauchdünne magnetische Materialien für zukünftige Quantentechnologien entwickelt

Zweidimensionale magnetische Strukturen gelten als vielversprechendes Material für neuartige Datenspeicher, da sich die magnetischen Eigenschaften einzelner Molekülen untersuchen und verändern lassen. Forscher haben nun erstmals einen hauchdünnen Ferrimagneten hergestellt, bei dem sich Moleküle mit verschiedenen magnetischen Zentren auf einer Goldfläche selbst zu einem Schachbrettmuster anordnen. Dies berichten Wissenschaftler des Swiss Nanoscience Institutes der Universität Basel und des Paul Scherrer Institutes in der Wissenschaftszeitschrift «Nature Communications».

Ferrimagneten besitzen zwei magnetische Zentren, deren Magnetismus verschieden stark ist und in entgegengesetzte Richtungen zeigt. Zweidimensionale, quasi...

Im Focus: Neuer Ionisationsweg in molekularem Wasserstoff identifiziert

„Wackelndes“ Molekül schüttelt Elektron ab

Wie reagiert molekularer Wasserstoff auf Beschuss mit intensiven ultrakurzen Laserpulsen? Forscher am Heidelberger MPI für Kernphysik haben neben bekannten...

Im Focus: Wafer-thin Magnetic Materials Developed for Future Quantum Technologies

Two-dimensional magnetic structures are regarded as a promising material for new types of data storage, since the magnetic properties of individual molecular building blocks can be investigated and modified. For the first time, researchers have now produced a wafer-thin ferrimagnet, in which molecules with different magnetic centers arrange themselves on a gold surface to form a checkerboard pattern. Scientists at the Swiss Nanoscience Institute at the University of Basel and the Paul Scherrer Institute published their findings in the journal Nature Communications.

Ferrimagnets are composed of two centers which are magnetized at different strengths and point in opposing directions. Two-dimensional, quasi-flat ferrimagnets...

Alle Focus-News des Innovations-reports >>>

Anzeige

Anzeige

IHR
JOB & KARRIERE
SERVICE
im innovations-report
in Kooperation mit academics
Veranstaltungen

Aachener Werkzeugmaschinen-Kolloquium 2017: Internet of Production für agile Unternehmen

23.05.2017 | Veranstaltungen

14. Dortmunder MST-Konferenz zeigt individualisierte Gesundheitslösungen mit Mikro- und Nanotechnik

22.05.2017 | Veranstaltungen

Branchentreff für IT-Entscheider - Rittal Praxistage IT in Stuttgart und München

22.05.2017 | Veranstaltungen

 
VideoLinks
B2B-VideoLinks
Weitere VideoLinks >>>
Aktuelle Beiträge

Mikro-Lieferservice für Dünger

23.05.2017 | Biowissenschaften Chemie

RWI/ISL-Containerumschlag-Index sinkt nach März-Hoch

23.05.2017 | Wirtschaft Finanzen

Workshop: Future Trends in DNA-based Nanotechnology vom 29. Mai bis 2. Juni 17

23.05.2017 | Seminare Workshops